Alison Keetley¹, Thierry Facon², Jesus San-Miguel³, Saad Z. Usmani⁴, Meletios A. Dimopoulos⁵, Shaji Kumar⁶, Maria-Victoria Mateos⁷, Michele Cavo⁸, Bart Heeg⁹, Sophie van Beekhuizen⁹, Marta Pisini¹⁰, Sandhya Nair¹¹, Annette Lam¹², Mary Slavcev¹², Jianming He¹² (1.Janssen Asia Pacific Pte Ltd, Singapore, Republic of Singapore, 2.Hôpital Claude Huriez, CHRU Lille, Lille, France Metropolitan, 3.Clínica Universidad de Navarra-CIMA, IDISNA, CIBERONC, Pamplona, Spain, 4.Levine Cancer Institute/Atrium Health, Charlotte, NC, United States of America, 5.National and Kapodistrian University of Athens, Athens, Hellenic Republic, 6.Department of Hematology, Mayo Clinic Rochester, Rochester, MN, United States of America, 7.University Hospital of Salamanca/IBSAL, Salamanca, Spain, 8.Seràgnoli Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italian Republic, 9.Ingress Health, Rotterdam, Kingdom of the Netherlands, 10.Janssen EMEA, Beerse, Kingdom of Belgium, 11.Janssen Pharmaceutica NV, Beerse, Kingdom of Belgium, 12.Janssen Global Services, Raritan, NJ, United States of America)

Munira Borhany, Sidra Zafar, Madiha Abid, Tahir Shamsi (National Institute of Blood Disease and Bone Marrow Transplantation, Karachi, Pakistan, Islamic Republic of Pakistan)

Anja Seckinger¹, Martina Emde¹, Susanne Beck¹, Anna Jauch², Marcel Mohr^1,2, Thomas Hielscher³, Thierry Reme⁴, Anna Marciniak-Czochra², Veronique Pantesco⁴, Bernard Klein⁴, Dirk Hose¹ (1.Heidelberg University Hospital, Heidelberg, BW, Federal Republic of Germany, 2.Heidelberg University, Heidelberg, BW, Federal Republic of Germany, 3.German Cancer Research Center, Heidelberg, BW, Federal Republic of Germany, 4.CHU Montpellier, Montpellier, Herault, French Republic)

Hiroki Kobayashi, Toshiki Terao, Takafumi Tsushima, Yoshiaki Abe, Kentaro Narita, Akihiro Kitadate, Daisuke Miura, Masami Takeuchi, Kosei Matsue (Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center)

Shiro Koh^1,2, Kumiyo Nakai^1,2, Yusuke Kizawa¹, Hiroyoshi Ichihara¹, Shoji Ine¹, Atsuko Mugitani¹ (1.Hematology, Fuchu hospital, Osaka, Japan, 2.Hematology, Osaka City University, Osaka, Japan)

Hiroshi Handa¹, Hiromi Koiso¹, Morio Matsumoto², Kayoko Murayama³, Hiroaki Shimizu¹, Takuma Ishizaki¹, Takayuki Saito⁴, Akio Saito², Hisashi Takei¹, Nobuhiko Kobayashi¹, Hirono Iriuchishima², Tetsuya Ishikawa¹, Yuri Miyazawa¹, Makiko Takizawa¹, Akihiko Yokohama⁵, Yohei Osaki⁶, Norifumi Tsukamoto⁶, Yoshiyuki Ogawa¹, Hirokazu Murakami⁴ (1.Hematology, Gunma University, Maebashi, Japan, 2.Hematology, NHO Shibukawa Medical Center, Shibukawa, Japan, 3.Hematology, Gunma Cancer Center, Oota, Japan, 4.Health Science, Gunma University, Maebashi, Japan, 5.Blood Transfusion Service, Gunma University, Maebashi, Japan, 6.Oncology Center, Gunma University, Maebashi, Japan)